Suplac

Suplac

bromocriptine

Manufacturer:

Biolab

Distributor:

Biopharm
Concise Prescribing Info
Contents
Bromocriptine mesylate
Indications/Uses
Listed in Dosage.
Dosage/Direction for Use
Female infertility 1.25 mg for 1st few days then increase to 2.5 mg bid-tid. Male infertility 5-10 mg/day. Galactorrhea &/or amenorrhea 1.25-2.5 mg once daily for 2-3 days then increase to 2.5 mg bid. Prevention & suppression of lactation 2.5 mg daily for 2-3 days then increase to 2.5 mg bid for 14 days.
Administration
Should be taken with food.
Special Precautions
Hyperprolactinemia (possible pituitary tumour); peptic ulcer or Gl bleeding; CV & liver disease, history of psychotic disorders; affects ability to drive or operate machinery; mastalgia & nodular cystic breast alterations (exclude malignancy). Pregnancy, lactation.
Adverse Reactions
Gl disturbances, dizziness, orthostatic hypotension; syncope, headache, drowsiness; dry mouth; altered liver function tests; dyskinesia; CNS disturbances; leg cramps (reduce dose); peripheral vasospasm (prolonged use).
Drug Interactions
Phenothiazines, butyrophenones, thioxanthenes & metoclopramide may reduce the prolactin-lowering effect of bromocriptine. Erythromycin may increase bromocriptine plasma conc. Tolerance may be reduced by alcohol.
ATC Classification
G02CB01 - bromocriptine ; Belongs to the class of prolactine inhibitors. Used to suppress lactation.
Presentation/Packing
Form
Suplac tab 2.5 mg
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in